Table 3 of Lu, Mol Vis 2012; 18:2255-2264.

Table 3. Allogeneic T lymphocyte stimulatory capacity of DCs.

  DCs treatment


DCs/T cell ratio

LPS
LPS + 25%
supernatant
LPS + 50%
supernatant		 LPS + 50%
supernatant +
TGF-β2 antibody
1/10 11.57±0.54 8.16±0.46A 4.83±0.31AB 7.84±0.45C
1/20 6.81±0.32 7.47±0.39A 3.02±0.29AB 4.82±0.28C
1/50 3.96±0.40 3.03±0.31A 1.95±0.23AB 2.74±0.25C
1/100 2.32±0.27 1.80±0.28NS 1.23±0.24ANS 1.63±0.22C

Data represent mean value±standard deviation of stimulate index (SI). A, p<0.05 compared with DCs treated with LPS; B, p<0.05 compared with DCs treated with LPS + 25% CSCs culture supernatant; C, p<0.05 compared with DCs treated with LPS + 50% CSCs culture supernatant; NS, no significance.

Lu, Mol Vis 2012; 18:2255-2264. http://www.molvis.org/molvis/v18/a239

©2012 Molecular Vision http://www.molvis.org/molvis/

ISSN 1090-0535